Personalized recombinant Idiotype vaccination after chemotherapy as initial treatment for mantle cell lymphoma.

被引:0
|
作者
Leonard, J
Vose, J
Timmerman, J
Levy, R
Ingolia, D
Denney, D
Coleman, M
Kunkel, L
机构
[1] Cornell Univ, Weill Med Coll, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY USA
[3] Univ Nebraska, Med Ctr, Omaha, NE USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[5] Genitope Corp, Redwood City, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4792
引用
收藏
页码:312B / 312B
页数:1
相关论文
共 50 条
  • [31] Autologous stem cell transplantation and rituximab for mantle cell lymphoma.
    Capote, FJ
    González-Barca, E
    Bergua, JM
    Pascual, MJ
    García-Boyero, R
    Ribera, JM
    Jiménez, A
    Romero, A
    Giraldo, P
    Fernández-Calvo, J
    Ramírez, J
    Amigo, ML
    Muñoz, MI
    Caballero, D
    Guinot, M
    Oriol, A
    Queizán, JA
    Cantalapiedra, A
    Moraleda, JM
    Grande, C
    Palomera, L
    Almagro, M
    Leon, A
    Fernández-Sevilla, A
    Gil, JL
    BLOOD, 2005, 106 (11) : 592A - 592A
  • [32] Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.
    Park, In-Woo
    Reddy, M. V. Ramana
    Reddy, E. Premkumar
    Groopman, Jerome E.
    BLOOD, 2006, 108 (11) : 270B - 270B
  • [33] Current strategies in mantle cell lymphoma. Conventional therapy
    Dreyling, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 48
  • [34] Development of a novel prognostic score for mantle cell lymphoma.
    Adams, I
    Taylor, PRA
    Jackson, GH
    Angus, B
    Watson, P
    Mounter, P
    McKay, P
    Dickinson, AM
    Oliver, K
    Jack, F
    BLOOD, 2000, 96 (11) : 220B - 220B
  • [35] RITUXIMAB OF MAINTENANCE IN MANTLE CELL LYMPHOMA. EXPERIENCE OF A CENTRE
    Quintana Ana, Sanchez
    Cristina, Notario
    Carmen, Marrero
    Nuria, Hernanz
    Pablo, Rios
    Joaquin, Brena
    Hector, Gonzalez
    Ana, Cabello
    Ana, Oliva
    Ana, Leon
    Mario, Rios
    Alexander, Figueroa
    Patricia, Hernandez
    Yaxiraxi, Lorenzo
    Alejandro, Marin
    Maria Carmen, Mesa
    HAEMATOLOGICA, 2016, 101 : 227 - 227
  • [36] Multimodal dose dense therapy for mantle cell lymphoma.
    Wanko, SO
    Gockerman, JP
    Moore, JO
    de Castro, C
    Diehl, L
    Pronitz, R
    Gasparetto, C
    Chute, J
    Horwitz, M
    Morris, A
    Ali-Osman, F
    Rao, A
    Niedzweicki, D
    Long, GD
    Chao, NJ
    Rizzieri, DA
    BLOOD, 2005, 106 (11) : 463B - 463B
  • [37] Composite mantle cell and follicular lymphoma. A case report
    ILgenfritz, Raquel B.
    Le Tourneau, Agnes
    Arborio, Michel
    Molina, Thierry J.
    Diebold, Jacques
    Damotte, Diane
    Audouin, Josee
    HUMAN PATHOLOGY, 2009, 40 (02) : 259 - 263
  • [38] Comprehensive molecular cytogenetic analysis of mantle cell lymphoma.
    Leupolt, E
    Bullinger, L
    Bentz, M
    Ott, G
    Müller-Hermelink, HK
    Barth, TFE
    Möller, P
    Lichter, P
    Döhner, H
    Stilgenbauer, S
    BLOOD, 1999, 94 (10) : 517A - 517A
  • [39] Cytogenetic abnormalities in eleven cases with Mantle Cell Lymphoma.
    Espinet, B
    Sole, F
    Lloveras, E
    Woessner, S
    Perez, A
    Florensa, L
    Besses, C
    SansSabrafen, J
    CYTOGENETICS AND CELL GENETICS, 1997, 77 (1-2): : P312 - P312
  • [40] Multimodal dose dense therapy for mantle cell lymphoma.
    Wanko, SO
    Gocherman, JP
    Moore, JO
    Decastro, C
    Prosnitz, R
    Gasparetto, C
    Chute, J
    Horowitz, M
    Ashley, M
    Emily, E
    Patty, D
    Nelson, CJ
    Rizzieri, DA
    BLOOD, 2004, 104 (11) : 329A - 330A